Microorganism |
|
|
|
Antimicrobial |
|
|
Reference |
Staphylococcus aureus (FDA 209P) |
- |
- |
0.008 - ? |
Sitafloxacin |
332 |
Staphylococcus aureus (FDA 209P) |
- |
- |
0.016 - ? |
DU-6856 |
332 |
Staphylococcus aureus (FDA 209P) |
- |
- |
0.016 - ? |
Imipenem |
349 |
Staphylococcus aureus (FDA 209P) |
- |
- |
0.063 - ? |
DU-6857 |
332 |
Staphylococcus aureus (FDA 209P) |
- |
- |
0.25 - ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
332 |
Staphylococcus aureus (FDA 209P) |
- |
- |
0.25 - ? |
Levofloxacin (Levaquin, Quixin) |
332 |
Staphylococcus aureus (FDA 209P) |
- |
- |
0.25 - ? |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
349 |
Staphylococcus aureus (FDA 209P) |
- |
- |
0.39 - ? |
Carbenicillin (Pyopen, Geogen, Geocillin) |
616 |
Staphylococcus aureus (FDA 209P) |
- |
- |
0.39 - ? |
Carbenicillin (Pyopen, Geogen, Geocillin) |
616 |
Staphylococcus aureus (FDA 209P) |
- |
- |
0.39 - ? |
Carbenicillin (Pyopen, Geogen, Geocillin) |
616 |
Staphylococcus aureus (FDA 209P) |
- |
- |
0.39 - ? |
Carbenicillin (Pyopen, Geogen, Geocillin) |
616 |
Staphylococcus aureus (FDA 209P) |
- |
- |
0.39 - ? |
Carbenicillin (Pyopen, Geogen, Geocillin) |
616 |
Staphylococcus aureus (FDA 209P) |
- |
- |
0.39 - ? |
Carbenicillin (Pyopen, Geogen, Geocillin) |
616 |
Staphylococcus aureus (FDA 209P) |
- |
- |
0.5 - ? |
Ampicillin (Omnipen) |
349 |
Staphylococcus aureus (FDA 209P) |
- |
- |
0.5 - ? |
Cefmetazole |
349 |
Staphylococcus aureus (FDA 209P) |
- |
- |
0.5 - ? |
Ofloxacin (Floxin) |
332 |
Staphylococcus aureus (FDA 209P) |
- |
- |
1 - ? |
Cefoxitin (Mefoxin) |
349 |
Staphylococcus aureus (FDA 209P) |
- |
- |
1 - ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
349 |
Staphylococcus aureus (FDA 209P) |
- |
- |
2 - ? |
Metronidazole (Flagyl) |
105 |
Staphylococcus aureus (FDA 209P) |
- |
- |
3.13 - ? |
SCE-129 |
616 |
Staphylococcus aureus (FDA 209P) |
- |
- |
3.13 - ? |
SCE-129 |
616 |
Staphylococcus aureus (FDA 209P) |
- |
- |
3.13 - ? |
SCE-129 |
616 |
Staphylococcus aureus (FDA 209P) |
- |
- |
3.13 - ? |
SCE-129 |
616 |
Staphylococcus aureus (FDA 209P) |
- |
- |
3.13 - ? |
SCE-129 |
616 |
Staphylococcus aureus (FDA 209P) |
- |
- |
3.13 - ? |
SCE-129 |
616 |
Staphylococcus aureus (FDA 209P) |
- |
- |
4 - ? |
Piperacillin (Pipracil) |
349 |